MolNFT v1 · #94928 · protein
Bovine beta-lactoglobulin (isoform a) in complex with lauric acid (C12)
4IB6: “Bovine beta-lactoglobulin (isoform a) in complex with lauric acid (C12)”. X-ray diffraction, 1 ligand (DAO), 1 pocket (best druggability 0.70). MolNFT v1 #94928 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4IB6
- Type
- protein
- Length
- 158 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-lactoglobulin
- UniProt
- P02754
- Ligands
- DAO
- Pockets
- 1 · best druggability 0.70
Structure
x-ray diffraction · 1 distinct chain · 16% helix, 42% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-lactoglobulin | protein | 158 | 16% helix, 42% strand | P02754 |
Ligands and binding sites
- DAO · Lauric acid · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 232 | 0.70 | 0.85 | 32 | DAO |
Modifications
Observed in the structure: 2 disulfide (disulfide).
Compared structures
- 4IB6 · Bovine beta-lactoglobulin (isoform A) in complex with lauric acid (C12) · the same entry in another collection · chain A against A, TM-score 1.00
- P02754 · AlphaFold monomer V2.0 prediction for beta-lactoglobulin (P02754) · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P02754
- Elsewhere: RCSB PDB 4IB6 · PDBe 4IB6 · UniProt P02754
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.